NCT04546984View on ClinicalTrials.gov

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 29, 2020

Study Completion Date

December 29, 2020

Conditions
Nonalcoholic Steatohepatitis (NASH)
Interventions
DRUG

HEC96719

Part 2：Mulltiple doses up to 10 days

Trial Locations (1)

Unknown

The Shanghai xuhui district central hospital, Shanghai

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT04546984 - Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter